{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T13:01:04Z","timestamp":1791550864036,"version":"4.3.4"},"reference-count":70,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:00:00Z","timestamp":1721001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030719","name":"National Institute of Health Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030719","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["20\/COV\/8549"],"award-info":[{"award-number":["20\/COV\/8549"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["SFI 20\/COV\/8566"],"award-info":[{"award-number":["SFI 20\/COV\/8566"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.heliyon.2024.e34694","type":"journal-article","created":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T17:36:53Z","timestamp":1721756213000},"page":"e34694","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Early inflammatory profiles predict maximal disease severity in COVID-19: An unsupervised cluster analysis"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9646-7910","authenticated-orcid":false,"given":"Grace","family":"Kenny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurvin","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colette Marie","family":"Gaillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riya","family":"Negi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Alalwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Garcia Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"McCann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willard","family":"Tinago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoife G.","family":"Cotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eoghan","family":"de Barra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Horgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Obada","family":"Yousif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Gautier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Landay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"McAuley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eoin R.","family":"Feeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"O'Kane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick WG.","family":"Mallon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e34694_bib1","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41586-020-2562-8","article-title":"Zoonotic host diversity increases in human-dominated ecosystems","volume":"584","author":"Gibb","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2024.e34694_bib2","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2105482118","article-title":"Intensity and frequency of extreme novel epidemics","volume":"118","author":"Marani","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.heliyon.2024.e34694_bib3","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.heliyon.2024.e34694_bib4","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2024.e34694_bib5","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2024.e34694_bib6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bbrc.2020.11.021","article-title":"COVID19- clinical presentation and therapeutic considerations","volume":"538","author":"Kenny","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.heliyon.2024.e34694_bib7","first-page":"5803","article-title":"The importance of understanding the stages of COVID-19 in treatment and trials","volume":"23","author":"Griffin","year":"2021","journal-title":"AIDS Rev."},{"key":"10.1016\/j.heliyon.2024.e34694_bib8","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with covid-19","volume":"384","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2024.e34694_bib10","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1080\/17512433.2021.1949286","article-title":"Tocilizumab for the treatment of non\u2010critical COVID\u201019 pneumonia: an overview of the rationale and clinical evidence to date","volume":"14","author":"Kenny","year":"2021","journal-title":"Expet Rev. Clin. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e34694_bib11","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1002\/oby.23526","article-title":"Individuals with obesity who survive SARS\u2010CoV\u20102 infection have preserved antigen specific T cell frequencies","volume":"30","author":"Wrigley Kelly","year":"2022","journal-title":"Obesity"},{"key":"10.1016\/j.heliyon.2024.e34694_bib12","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.29058","article-title":"Risk factors associated with in-hospital mortality in a US national sample of patients with COVID-19","volume":"3","author":"Rosenthal","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.heliyon.2024.e34694_bib13","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.144455","article-title":"An immune-based biomarker signature is associated with mortality in COVID-19 patients","volume":"6","author":"Abers","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.heliyon.2024.e34694_bib14","doi-asserted-by":"crossref","DOI":"10.1093\/biomethods\/bpac028","article-title":"Molecular markers for early stratification of disease severity and progression in COVID-19","volume":"7","author":"Kashyap","year":"2022","journal-title":"Biol Methods Protoc"},{"key":"10.1016\/j.heliyon.2024.e34694_bib15","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jaci.2020.04.027","article-title":"Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19","volume":"146","author":"Yang","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.heliyon.2024.e34694_bib16","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1038\/s41467-021-25191-5","article-title":"The cytokines HGF and CXCL13 predict the severity and the mortality in COVID-19 patients","volume":"12","author":"Perreau","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heliyon.2024.e34694_bib17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S2213-2600(19)30369-8","article-title":"Development and validation of parsimonious algorithms to classify acute respiratory distress syndrome phenotypes: a secondary analysis of randomised controlled trials","volume":"8","author":"Sinha","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.heliyon.2024.e34694_bib18","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S2213-2600(17)30294-1","article-title":"Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study","volume":"5","author":"Scicluna","year":"2017","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.heliyon.2024.e34694_bib19","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S2213-2600(16)00046-1","article-title":"Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study","volume":"4","author":"Davenport","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.heliyon.2024.e34694_bib20","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1164\/rccm.202105-1302OC","article-title":"Latent class analysis reveals COVID-19\u2013related acute respiratory distress syndrome subgroups with differential responses to corticosteroids","volume":"204","author":"Sinha","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.heliyon.2024.e34694_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab122","article-title":"Dynamic change and clinical relevance of postinfectious SARS-CoV-2 antibody responses","volume":"8","author":"Mallon","year":"2021","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.heliyon.2024.e34694_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2022.113345","article-title":"Performance and validation of an adaptable multiplex assay for detection of serologic response to SARS-CoV-2 infection or vaccination","volume":"510","author":"Kenny","year":"2022","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.heliyon.2024.e34694_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.micinf.2023.105247","article-title":"Associations between host microbiome and inflammation suggest role for host microbiome in driving COVID-19 disease severity","volume":"26","author":"MacCann","year":"2024","journal-title":"Microb. Infect."},{"key":"10.1016\/j.heliyon.2024.e34694_bib24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13613-020-00706-3","article-title":"Clinical outcomes of COVID-19 in Wuhan, China: a large cohort study","volume":"10","author":"Liu","year":"2020","journal-title":"Ann. Intensive Care"},{"key":"10.1016\/j.heliyon.2024.e34694_bib25","doi-asserted-by":"crossref","first-page":"7015","DOI":"10.1038\/s41467-023-42717-1","article-title":"Distinct receptor binding domain IgG thresholds predict protective host immunity across SARS-CoV-2 variants and time","volume":"14","author":"Kenny","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heliyon.2024.e34694_bib26","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa186","article-title":"Inflammatory phenotypes predict changes in arterial stiffness following antiretroviral therapy initiation","author":"Kelly","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.heliyon.2024.e34694_bib27","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsac212","article-title":"Biomarker associations with insomnia and secondary sleep outcomes in persons with and without HIV in the POPPY-Sleep substudy: a cohort study","volume":"45","author":"Bakewell","year":"2022","journal-title":"Sleep"},{"key":"10.1016\/j.heliyon.2024.e34694_bib29","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.2307\/2532457","article-title":"Assessing proportionality in the proportional odds model for ordinal logistic regression","volume":"46","author":"Brant","year":"1990","journal-title":"Biometrics"},{"key":"10.1016\/j.heliyon.2024.e34694_bib30","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2024.e34694_bib31","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-052777","article-title":"Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies","volume":"11","author":"Mahamat-Saleh","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.heliyon.2024.e34694_bib32","doi-asserted-by":"crossref","DOI":"10.18637\/jss.v045.i03","article-title":"Mice : multivariate imputation by chained equations in R","volume":"45","author":"Buuren","year":"2011","journal-title":"J. Stat. Software"},{"key":"10.1016\/j.heliyon.2024.e34694_bib33","unstructured":"Mallon, Patrick WG, Crispie F, Gonzalez G, et al. Whole-genome sequencing of SARS-CoV-2 in the Republic of Ireland during waves 1 and 2 of the pandemic. medRxiv DOI:doi.org\/10.1101\/2021.02.09.21251402."},{"key":"10.1016\/j.heliyon.2024.e34694_bib34","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1067\/mai.2003.1333","article-title":"IL-13 receptors and signaling pathways: an evolving web","volume":"111","author":"Hershey","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.heliyon.2024.e34694_bib35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1465-9921-8-51","article-title":"IL-13-induced proliferation of airway epithelial cells: mediation by intracellular growth factor mobilization and ADAM17","volume":"8","author":"Booth","year":"2007","journal-title":"Respir. Res."},{"key":"10.1016\/j.heliyon.2024.e34694_bib36","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.3390\/ijms22052721","article-title":"A narrative review on plasminogen activator inhibitor-1 and its (Patho)Physiological role: to target or not to target?","volume":"22","author":"Sillen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e34694_bib37","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.immuni.2021.05.010","article-title":"Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease","volume":"54","author":"Bergamaschi","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.heliyon.2024.e34694_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120703","article-title":"SARS-CoV-2 infection- induced growth factors play differential roles in COVID-19 pathogenesis","volume":"304","author":"Gupta","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.heliyon.2024.e34694_bib39","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/thx.2004.034785","article-title":"Vascular endothelial growth factor gene polymorphism and acute respiratory distress syndrome","volume":"60","author":"Medford","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.heliyon.2024.e34694_bib40","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/thx.54.2.150","article-title":"Treatment of adult respiratory distress syndrome: plea for rescue therapy of the alveolar epithelium","volume":"54","author":"Berthiaume","year":"1999","journal-title":"Thorax"},{"key":"10.1016\/j.heliyon.2024.e34694_bib41","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1165\/rcmb.2012-0100TR","article-title":"Human epidermal growth factor receptor signaling in acute lung injury","volume":"47","author":"Finigan","year":"2012","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.heliyon.2024.e34694_bib42","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.rmed.2019.08.003","article-title":"VEGF and FGF-2: promising targets for the treatment of respiratory disorders","volume":"156","author":"Laddha","year":"2019","journal-title":"Respir. Med."},{"key":"10.1016\/j.heliyon.2024.e34694_bib43","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s13054-021-03596-4","article-title":"Distinct temporal characteristics of circulating alveolar epithelial and endothelial injury markers in ARDS with COVID-19","volume":"25","author":"Tojo","year":"2021","journal-title":"Crit. Care"},{"key":"10.1016\/j.heliyon.2024.e34694_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105748","article-title":"Early alveolar epithelial cell necrosis is a potential driver of COVID-19-induced acute respiratory distress syndrome","volume":"26","author":"Tojo","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.heliyon.2024.e34694_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1166574","article-title":"Dysregulated early transcriptional signatures linked to mast cell and interferon responses are implicated in COVID-19 severity","volume":"14","author":"MacCann","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e34694_bib46","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1016\/j.cell.2021.08.016","article-title":"The interferon landscape along the respiratory tract impacts the severity of COVID-19","volume":"184","author":"Sposito","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2024.e34694_bib47","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.chom.2016.01.007","article-title":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice","volume":"19","author":"Channappanavar","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.heliyon.2024.e34694_bib48","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-I- and type-II-interferon-mediated signalling","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.heliyon.2024.e34694_bib49","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.abc2061","article-title":"Type I and III interferons disrupt lung epithelial repair during recovery from viral infection","volume":"369","author":"Major","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.heliyon.2024.e34694_bib50","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1164\/rccm.202209-1838ED","article-title":"Understanding the role of mesenchymal stromal cells in treating COVID-19 acute respiratory distress syndrome","volume":"207","author":"O'Kane","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.heliyon.2024.e34694_bib51","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13054-022-03930-4","article-title":"Treatment of COVID-19-associated ARDS with mesenchymal stromal cells: a multicenter randomized double-blind trial","volume":"26","author":"Monsel","year":"2022","journal-title":"Crit. Care"},{"key":"10.1016\/j.heliyon.2024.e34694_bib52","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abm7853","article-title":"Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity","volume":"14","author":"Chakraborty","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.heliyon.2024.e34694_bib53","article-title":"COVID-19 severity is associated with differential antibody fc-mediated innate immune functions","volume":"12","author":"Adeniji","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.heliyon.2024.e34694_bib54","article-title":"Plasma markers of disrupted gut permeability in severe COVID-19 patients","volume":"12","author":"Giron","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e34694_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e09230","article-title":"Severe COVID-19 is characterised by inflammation and immature myeloid cells early in disease progression","volume":"8","author":"Townsend","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.heliyon.2024.e34694_bib56","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0140-6736(23)00510-X","article-title":"Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial","volume":"401","author":"Abani","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2024.e34694_bib57","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1001\/jama.2021.18295","article-title":"Effect of 12 mg vs 6 mg of dexamethasone on the number of days alive without life support in adults with COVID-19 and severe hypoxemia: the COVID STEROID 2 randomized trial","volume":"326","author":"Russell","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.heliyon.2024.e34694_bib58","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abd1554","article-title":"Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19","volume":"5","author":"Lee","year":"2020","journal-title":"Sci Immunol"},{"key":"10.1016\/j.heliyon.2024.e34694_bib59","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/infdis\/jiab035","article-title":"Immune profiling to determine early disease trajectories associated with coronavirus disease 2019 mortality rate: a substudy from the ACTT-1 trial","volume":"223","author":"Thiede","year":"2021","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.heliyon.2024.e34694_bib60","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109123118","article-title":"High-dimensional profiling reveals phenotypic heterogeneity and disease-specific alterations of granulocytes in COVID-19","volume":"118","author":"Lourda","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.heliyon.2024.e34694_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.659018","article-title":"Immunological biomarkers of fatal COVID-19: a study of 868 patients","volume":"12","author":"Mart\u00edn-S\u00e1nchez","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e34694_bib62","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1038\/s41591-020-1038-6","article-title":"A dynamic COVID-19 immune signature includes associations with poor prognosis","volume":"26","author":"Laing","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.heliyon.2024.e34694_bib63","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/s41467-022-28621-0","article-title":"Stratification of hospitalized COVID-19 patients into clinical severity progression groups by immuno-phenotyping and machine learning","volume":"13","author":"Mueller","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heliyon.2024.e34694_bib64","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","article-title":"Longitudinal analyses reveal immunological misfiring in severe COVID-19","volume":"584","author":"Lucas","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2024.e34694_bib65","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abg9873","article-title":"Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19","volume":"6","author":"Thwaites","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.heliyon.2024.e34694_bib66","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abd6197","article-title":"Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19","volume":"5","author":"Mann","year":"2020","journal-title":"Sci Immunol"},{"key":"10.1016\/j.heliyon.2024.e34694_bib67","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc8511","article-title":"Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications","volume":"369","author":"Mathew","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.heliyon.2024.e34694_bib68","doi-asserted-by":"crossref","DOI":"10.18103\/mra.v11i8.4300","article-title":"Neutrophil\/lymphocyte ratio (NLR) and lym-phocyte\/CRP ratio (LCR) are reliable pre-dictors of adverse out-comes in high-altitude COVID-19 patients","volume":"11","author":"Aguilar","year":"2023","journal-title":"Med Res Arch"},{"key":"10.1016\/j.heliyon.2024.e34694_bib69","first-page":"e6","article-title":"Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19","volume":"81","author":"Liu","year":"2020","journal-title":"J. Infect."},{"key":"10.1016\/j.heliyon.2024.e34694_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1157651","article-title":"Long COVID: clinical characteristics, proposed pathogenesis and potential therapeutic targets","volume":"10","author":"Kenny","year":"2023","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.heliyon.2024.e34694_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1385858","article-title":"Identification of inflammatory clusters in long-COVID through analysis of plasma biomarker levels","volume":"15","author":"Dhingra","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e34694_bib72","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1186\/s12879-023-08783-y","article-title":"Impact of vaccination and variants of concern on long COVID clinical phenotypes","volume":"23","author":"Kenny","year":"2023","journal-title":"BMC Infect. Dis."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024107256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024107256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T21:42:10Z","timestamp":1784065330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024107256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":70,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2405844024107256"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34694","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early inflammatory profiles predict maximal disease severity in COVID-19: An unsupervised cluster analysis","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34694","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e34694"}}